Weiss Asset Management’s Akero Therapeutics AKRO Stock Holding History

Weiss Asset Management’s Portfolio AKRO Stock Details AKRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-486,000	Closed	-$23.1M	–	576
2025 Q3	$23.1M	Buy	486,000 +457,474	+1,604%	+$22.2M	0.27%	50
2025 Q2	$1.52M	Buy	+28,526	New	+$1.3M	0.02%	282

Other funds holding AKRO

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Weiss Asset Management's AKRO Position: Q4 2025 in Review

Weiss Asset Management sold out of Akero Therapeutics (AKRO) in Q4 2025, closing a stake of 486,000 shares — an estimated $23.1M sold.

Weiss Asset Management first reported a position in AKRO in Q2 2025 and held it in 2 quarters. The position peaked at $23.1M in Q3 2025. 2 funds tracked by Wall St. Rank hold AKRO as of Q4 2025.

Weiss Asset Management reported no remaining Akero Therapeutics position as of Q4 2025 after selling out during the quarter.
Weiss Asset Management sold 486,000 Akero Therapeutics shares in Q4 2025, an estimated $23.1M.
Weiss Asset Management first reported a position in Akero Therapeutics in Q2 2025 and held it in 2 quarters.
Weiss Asset Management's Akero Therapeutics position peaked at $23.1M in Q3 2025.
2 funds tracked by Wall St. Rank held Akero Therapeutics as of Q4 2025.

Based on Weiss Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.